Interactions between cytokines and growth hormone for resistance to experimental Toxoplasma gondii infection

New Microbiologica

Volumn 23, Issue 2, 2000, Pages 167-183

  Benedetto, N ^a   Folgore, A ^a   Gorga, F ^a   Finamore, E ^a   Rao, M ^a   Galdiero, F ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH HORMONE; INTERLEUKIN DERIVATIVE; N(G) METHYLARGININE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; HUMAN; IMMUNOLOGY; METABOLISM; PARASITOLOGY; SERODIAGNOSIS; TOXOPLASMA; TOXOPLASMOSIS; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION MOLECULES; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENDOTHELIUM, VASCULAR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GROWTH HORMONE; HUMANS; INTERLEUKINS; NEUTRALIZATION TESTS; NITRIC OXIDE; OMEGA-N-METHYLARGININE; TOXOPLASMA; TOXOPLASMOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0041689381     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. ADAMS, L.B., HIBBS, J.B.SR., TAINTOR, R.R., and KRAHENBUHL, J.L. (1990). Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxide from L-arginine. Journal of Immunology, 144, 2725-2729.
2. ADAMS, D.H., and SHAW, S. (1994). Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet, 343, 831-836.
3. BENEDETTO, N., AURIAULT, C., DARCY, F., LANDO, D., WATIER, H., and CAPRON, A. (1991). Effect of rIFN-γ and IL-2 treatments in mouse and nude rat infections with Toxoplasma gondii. European Cytokine Network, 2, 107-114.
4. BENEDETTO, N., FOLGORE, A., GALDIERO, M., MELI, M., and DI CARLO, R. (1995). Effect of prolactin, rIFN-γ or rTNF-α in murine toxoplasmosis. Pathologie Biologie, 43, 395-400.
5. BENEDETTO, N., FOLGORE, A., FERRARA, C., MOLITIERNO, M., and GALDIERO, F. (1997). Effects of α-adrenergic agonists on Toxoplasma gondii replication in human umbilical vein endothelial cells. Pathologie Biologie, 45, 9-14.
6. BLALOCK, J.E. (1989). A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiological Reviews, 69, 1-32.
7. BOHNE, W., HEESEMANN, J., and GROSS, U. (1994). Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infection and Immunity, 62, 1761-1767.
8. CHANG, H.R., GRAU, G.E., and PECHÈRE, J.C. (1990). Role of TNF and IL-1 in infection with Toxoplasma gondii. Immunology, 69, 33-37.
9. CHANG, H.R., PECHÈRE, J.C., and PIGUET, P.F. (1992). Role of tumour necrosis factor in chronic murine Toxoplasma gondii encephalitis. Immunology infections Diseases, 2, 61-68.
10. CHAO, C.C., GEKKER, G., HU, S., and PETERSON, P.K. (1994). Human microglial cell defense against Toxoplasma gondii. Journal of Immunology, 152, 1246-1252.
11. COSMAN, D., LAYMAN, S.D., IDZERDA, R.L., BECKMANN, M.P., PARK, L.S., GOODWIN, R.G., and MARCH, C.J. (1990). A new cytokine receptor superfamily. Trends Biochemical Science, 15, 265-271.
12. DENIS, M., and GREGG, E.O. (1990). Recombinant interleukin-6 increases the intracellular and extracellular growth of Mycobacterium avium. Immunology, 71, 139-146.
13. DENIS, M. (1991). Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. Journal of leukocyte Biology, 49, 380-387.
14. DIMIER, I.H., and BOUT, D.T. (1993). Co-operation of interleukin-1β and tumor necrosis factor-α in the activation of human umbilical vein endothelial cells to inhibit Toxoplasma gondii replication. Immunology, 79, 336-338.
15. DOUKAS, J., and POBER, J.S. (1990). IFN-γ enhances endhothelial activation induced by tumor necrosis factor but not IL-1. Journal of Immunology, 145, 1727-1733.
16. EDWARDS III, C.K., YUNGER, L.M., LORENCE, R.M., DANTZER, R., and KELLEY, K.W. (1991a). The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proceedings of the National Academy of Science, 88, 2274-2277.
17. EDWARDS III, C.K., LORENCE, R.M., DUNHAM, D.M., ARKINS, S., YUNGER, L.M., GREAGER, J.A., WALTER, R.J., DANTZER, R., and KELLEY, K.W. (1991b). Hipophysectomy inhibits the synthesis of tumor necrosis factor α by rat macrophages: partial restoration by exogenous growth hormone or interferon γ. Endocrinology, 128, 989-996.
18. EDWARDS III, C.K., GHIASUDDIN, S.M., YUNGER, L.M., LORENCE, R.M., ARKINS, S., DANTZER, R., and KELLEY, K.W. (1992). In vivo administration of recombinant growth hormone or gamma Interferon activates macrophages: enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates. Infection and Immunity, 60, 2514-2521.
19. FU, Y.K., ARKINSY, S., FUH, G., CUNNINGHAM, B.C., WELLES, J.A., FONG, S., CRONIN, M.J., DANTZER, R., and KELLEY, K.W. (1992). Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. Journal Clinical Investigation, 89, 451-457.
20. FU, Y.K., ARKINS, S., LI, Y.M., DANTZER, R., and KELLLY, K.W. (1994). Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats: reversal by the combination of gamma interferon and growth hormone. Infection and Immunity, 62, 1-8.
21. FURTADO, G.C., SLOWIK, M., KLEINMAN, H.K., and JOINER, K.A. (1992). Laminin enhances binding of Toxoplasma gondii tachyzoites to J774 murine macrophage cells. Infection and Immunity, 60, 2337-2342.
22. GALA, R.R. (1991). Prolactin and growth hormone in the regulation of the immune system. Proceedings of the Society Experimental Biology Medicine, 198, 513-523.
23. GALDIERO, M., VITIELLO, M., SCARFOGLIERO, P., and SOMMESE, L. (1997). Growth hormone release of interleukin-1α, interferon-γ and interleukin-4 from murine splenocytes stimulated with staphylococcal protein A. toxic shock syndrome toxin-1 and streptococcal lysin S. European Cytokine Network, 8, 83-90.
24. GAZZINELLI, R.T., ELTOUM, I., WYNN, T.A., and SHER, A. (1993). Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. Journal of Immunology, 151, 3672-3681.
25. GREIL, J., BODENDORFER, B., ROLLINGHOFF, M., and SOLBACH, W. (1988). Application of recombinan granulocyte-macrophage colony-stimulating factor has a detrimental effect in experimental murine leishmaniasis. European Journal of Immunology, 18, 1527-1533.
26. HAYASHI, S., CHAN, C.C., GAZZINELLI, R., and ROBERGE, F.G. (1996). Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis. Journal of Immunology, 156, 1476-1481.
27. KHAN, I.A., MATSUURA, T., and KASPER, L.H. (1995). IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice. Parasite Immunology, 17, 185-195.
28. KHAN, I.A., MATSUURA, T., FONSEKA, S., and KASPER, L.H. (1996). Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii in IRF-1-/- mice. Journal of Immunology, 156, 636-643.
29. LANGERMANS, J.A.M., VAN DER HULST, M.E.B, NIBBERING, P.H, HIEMSTRA, P.S., FRANSEN, L., and VAN FURTH, R. (1992). IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α. Journal of Immunology, 148, 568-574.
30. LEEUWENBERG, J.F., DENTENER, M.A., and BUURMAN, W.A. (1994). Lipopolysaccharide (LPS)-mediated soluble TNF receptor release and TNF receptor expression by monocytes: role of CD14, LPS binding protein, and bactericidal/permeability- increasing protein. Journal of Immunology, 152, 5070-5076.
31. LIEW, F.Y., PARKINSON, C., MILLOT, S., SEVERN, A., and CARRIER, M. (1990). Tumor necrosis factor (TNF-α) in leishmaniasis. I. TNF-α mediates host protection against cutaneous leishmaniasis. Immunology, 69, 570-576.
32. MANTOVANI, A., and DEJANA, E. (1989). Cytokines as communication signals between leukocytes and endothelial cells. Immunology Today, 11, 370-375.
33. MURRAY, H.W., RUBIN, B.Y., CARRIERO, S.M., HARRIS, A.M., and JAFFEE, E.A. (1985). Human mononuclear phagocytes antiprotozoal mechanisms: oxigen- dependent vs oxigen- independent activity against intracellular Toxoplasma gondii. Journal of Immunology, 134, 1982-1988.
34. MURRAY, H.W., and TEITELBAUM, R.F. (1992). L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. Journal of Infectious Diseases 165, 513-517.
35. NORRBY, R. (1970). Host cell penetration of Toxoplasma gondii. Infection and Immunity, 2, 250-255.
36. PALMER, R.M.J., FERRRIGE, A.G., and MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327, 524-529.
37. PEETERMANS, W.E., ILSE RAATS, C.J., VAN FURTH, R., and LANGERMANS, J.A.M. (1995). Mycobacterial 65-kilodalton heat shock protein induces tumor necrosis factor alfa and interleukin 6, reative nitrogen intermediates, and toxoplasmastatic activity in murine peritoneal macrophages. Infection and Immunity, 63, 3454-3458.
38. PIGOTT, R., DILLON, L.P., HEMINGWAY, I.H., and GEARING, A.J.H. (1992). Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endhothelial cells. Biochemical and Biophysical Research Communications, 187, 584-589.
39. POBER, J.S., and COTRAN, R.S. (1990). Cytokines and endothelial cell biology. Physiological Reviews, 70, 427-451.
40. REED, S.G., NATHAN, C.F., PIHL, D.L., RODRICKS, P., SHANEBECK, K., CONLON, P.J., and GRABSTEIN, K.H. (1987). Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Journal of Experimental Medicine, 166, 1734-1746.
41. REMINGTON, J.S., and DESMONTS, G. (1983). Toxoplasmosis. In Infectious diseases of the fetus and newborn infant, 2nd ed. J.S. Remington and J.O. Klein, eds. The W.B. Saunders Co., Philadelphia, p 143-263.
42. SCARBOROUGH, D.E. (1990). Cytokine modulation of pituitary hormones. Annals of New York Academy Science, 594, 169-187.
43. SIBLEY, L.D., ADAMS, L.B., FUKUTOMI, Y., and KRAHENBUHL, J.L. (1991). Tumor necrosis factor-α triggers antitoxoplasmal activity of IFN-γ primed macrophages. Journal of Immunology, 147, 2340-2345.
44. SPRINGER, T.A. (1994). Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76, 301-314.
45. THARDIN, J.F., RINI, C.M., BERAUD, M., VANDAELE, J., FRISACH, M.F., ESSERIES, M.H., SEGUELA, J.P., and PIPY, B. (1993). Eicosanoid production by mouse peritoneal macrophages during Toxoplasma gondii penetration: role of parasite and host cell phospholipases. Infection and Immunity, 61, 1432-1441.
46. THYE YIN, E., GALANOS, C., KINSKY, S., BRADSHOW, R.A., WESSLER, S., LUDERITZ, O., and SARMIENTO, M.F. (1972). Picogram sensitive assay for endotoxin: gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharide and lipid A from Gram-negative bacteria. Biochemical Biophysical Acta, 261, 284-289.
47. WEIGENT, D.A. (1996). Immunoregulatory properties of growth hormone and prolactin. Pharmacology Therapy, 69, 237-257.
48. WERK, R. (1985). How does Toxoplasma gondii enter host cells? Review Infectious Diseases, 7, 449-457.
49. WIRTH, J.J., and KIERSZENBAUM, F. (1988). Recombinant tumor necrosis factor enhances macrophage destruction of Trypanosoma cruzi in the presence of bacterial endotoxin. Journal of Immunology, 141, 286-288.
50. WOODMAN, J.P., DIMIER, I.H., and BOUT, D. (1991). Human endothelial cells are activated by IFN-γ to inhibit Toxoplasma gondii replication. Journal of Immunology, 147, 2019-2023.